Zibo Dong

机构：Kanion Pharmaceutical (China) · ORCID：0009-0003-9379-0282

发表论文 44 篇 · 总被引 518 次 · h-index 13

代表论文

• Monotropein alleviates septic acute liver injury by restricting oxidative stress, inflammation, and apoptosis via the AKT (Ser473)/GSK3β (Ser9)/Fyn/NRF2 pathway (2024 · International Immunopharmacology · 被引 19)
• Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress (2023 · International Immunopharmacology · 被引 19)
• Monotropein induces autophagy through activation of the NRF2/PINK axis, thereby alleviating sepsis-induced colonic injury (2023 · International Immunopharmacology · 被引 15)
• Gypenoside XLIX alleviates acute liver injury: Emphasis on NF-κB/PPAR-α/NLRP3 pathways (2024 · International Immunopharmacology · 被引 13)
• Preparation, characterisation and in vitro anti-inflammatory activity of Baicalin microsponges (2024 · Heliyon · 被引 11)
• Liquiritigenin regulates MAPK (p38/JNK) signaling through inhibition of IRAK4, attenuates inflammatory response, fibrosis and kidney dysfunction in a high-salt diet induced chronic kidney disease (2025 · Chemico-Biological Interactions · 被引 10)